Cindy B Illescas, NP
Nurse Practitioner · Los Angeles
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 1 carrier
- Offices
- 3
- Since medical school
- 12 years
- Graduated 2014
Offices
3 locations · Special Service for Groups Inc · Mellow Medical Inc A Professional Corporation
Plans that list them
14 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Cindy B Illescas’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Original Medicare doctor bills
$13,335
Medicare paid this office $13,335 for 31 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 28 | $11,153 | $86 |
| New patient visit (60+ min) | 12 | $1,695 | $141 |
Who their Medicare patients are
31 Original Medicare patients in 2024. Average age 52 · Also on Medicaid 100% · Health risk score 1.11. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 52% · Depression 42%.
The office billed $61,235, Medicare allowed $18,278 and paid $13,335; for 149 services of 5 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 31 | 149 | 52 | 1.11 | $61,235 | $13,335 |
| 2023 | 16 | 63 | 55 | 1.36 | $16,603 | $3,657 |
| 2022 | 14 | 63 | 62 | 1.24 | $15,430 | $3,554 |
| 2021 | 18 | 38 | 69 | 1.52 | $10,220 | $2,433 |
| 2020 | 22 | 44 | 61 | 3.54 | $11,314 | $3,423 |
| 2019 | 56 | 68 | 62 | 2.64 | $18,951 | $3,812 |
| 2018 | 22 | 22 | 73 | 1.55 | $8,070 | $1,118 |
| 2017 | 141 | 149 | 73 | 1.20 | $46,083 | $6,913 |
| 2016 | 166 | 183 | 73 | 1.33 | $48,543 | $8,929 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2019: 1 service
| Emergency department visit with low level of medical decision making | 33 | $1,236 | $37 |
2017: 3 services
| New patient visit (30+ min) | 68 | $2,753 | $40 |
| Return visit (30+ min) | 49 | $2,394 | $47 |
| New patient visit (45+ min) | 11 | $995 | $90 |
2016: 4 services
| New patient visit (30+ min) | 50 | $2,541 | $51 |
| Short return visit (20+ min) | 57 | $2,067 | $35 |
| New patient visit (30+ min) | 18 | $1,347 | $75 |
| New patient visit (45+ min) | 12 | $989 | $82 |
Medicaid work
$22,607 in 2024
Medicaid paid $22,607 for 302 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 165 | $22,607 |
| Service | 137 | $0 |
| 2024 | 302 | 2 | 17 | $22,607 |
| 2023 | 522 | 3 | 24 | $34,902 |
| 2022 | 468 | 2 | 20 | $31,366 |
| 2021 | 550 | 2 | 26 | $37,057 |
| 2020 | 217 | 2 | 24 | $16,150 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 266 | $34,730 |
| Short return visit | 16 | $172 |
| Service | 240 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 247 | $31,366 |
| Service | 221 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 294 | $37,057 |
| Service | 256 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 131 | $16,150 |
| Service | 86 | $0 |
Drugs they prescribed that Part D paid
$157,465
Pharmacies billed $157,465 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 775) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
732 generic and 43 brand-name prescriptions · $157,465 in drug cost · 128 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Invega Sustenna | 26 | $80,438 | $3,094 |
| Aripiprazole | 20 | $6,942 | $347 |
| Olanzapine | 159 | $3,761 | $24 |
| Haloperidol | 46 | $1,360 | $30 |
| Clozapine | 16 | $991 | $62 |
See all 20 drugs
| Invega Sustenna | 26 | $80,438 | $3,094 |
| Aripiprazole | 20 | $6,942 | $347 |
| Olanzapine | 159 | $3,761 | $24 |
| Haloperidol | 46 | $1,360 | $30 |
| Clozapine | 16 | $991 | $62 |
| Divalproex | 40 | $952 | $24 |
| Valproic Acid | 27 | $860 | $32 |
| Olanzapine Odt | 18 | $759 | $42 |
| Haloperidol Decanoate | 18 | $715 | $40 |
| Benztropine Mesylate | 56 | $537 | $10 |
| Risperidone | 58 | $516 | $9 |
| Valproic Acid | 12 | $401 | $33 |
| Trazodone | 43 | $355 | $8 |
| Lithium Carbonate | 39 | $341 | $9 |
| Quetiapine | 14 | $235 | $17 |
| Duloxetine | 12 | $194 | $16 |
| Prazosin | 12 | $161 | $13 |
| Lamotrigine | 12 | $117 | $10 |
| Hydroxyzine | 11 | $87 | $8 |
| Topiramate | 13 | $75 | $6 |
Year by year
| 2024 | 775 | 39 | 0% (0) | 6% | $157,465 |
| 2023 | 409 | 26 | 0% (0) | 9% | $68,906 |
| 2022 | 269 | 28 | None | 6% | $42,386 |
| 2021 | 123 | 27 | None | None | $9,867 |
| 2020 | 70 | 20 | None | None | $1,523 |
| 2019 | 72 | 49 | None | None | $1,748 |
| 2018 | 95 | 61 | None | 19% | $2,212 |
| 2017 | 223 | 130 | 8% (17) | 17% | $3,659 |
| 2016 | 225 | 124 | 8% (19) | 12% | $4,097 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Invega Sustenna | 15 | $35,702 | $2,380 |
| Olanzapine | 105 | $3,047 | $29 |
| Divalproex | 25 | $896 | $36 |
| Haloperidol | 19 | $763 | $40 |
| Risperidone | 42 | $556 | $13 |
| Lithium Carbonate | 19 | $171 | $9 |
| Lamotrigine | 11 | $141 | $13 |
| Benztropine Mesylate | 11 | $125 | $11 |
| Bupropion | 11 | $115 | $10 |
| Trazodone | 11 | $98 | $9 |
2022: 8 drugs
| Divalproex | 32 | $830 | $26 |
| Aripiprazole | 12 | $652 | $54 |
| Olanzapine | 16 | $479 | $30 |
| Risperidone | 38 | $464 | $12 |
| Benztropine Mesylate | 29 | $306 | $11 |
| Escitalopram | 22 | $296 | $13 |
| Bupropion Xl | 12 | $289 | $24 |
| Gabapentin | 13 | $69 | $5 |
2021: 4 drugs
| Risperidone | 14 | $160 | $11 |
| Mirtazapine | 14 | $114 | $8 |
| Benztropine Mesylate | 11 | $94 | $9 |
| Sertraline | 16 | $93 | $6 |
2020: 1 drug
| Sertraline | 15 | $64 | $4 |
2017: 6 drugs
| Proair Hfa | 24 | $1,376 | $57 |
| Fluticasone Propionate | 22 | $218 | $10 |
| Cephalexin | 13 | $160 | $12 |
| Azithromycin | 25 | $148 | $6 |
| Prednisone | 18 | $52 | $3 |
| Tramadol | 11 | $34 | $3 |
2016: 7 drugs
| Proair Hfa | 12 | $649 | $54 |
| Amoxicillin-Clavulanate Potass | 11 | $161 | $15 |
| Fluticasone Propionate | 17 | $153 | $9 |
| Ibuprofen | 18 | $135 | $7 |
| Azithromycin | 12 | $97 | $8 |
| Tramadol | 16 | $72 | $4 |
| Prednisone | 15 | $50 | $3 |
Money from drug and device companies
$614 in 2025
| 2025 | 3 | 5 | None | $614 |
| 2024 | 5 | 9 | None | $667 |
| 2023 | 7 | 15 | None | $1,497 |
| 2022 | 9 | 13 | None | $1,324 |
| 2021 | 4 | 5 | None | $557 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Teva Pharmaceuticals USA | Uzedy | $370 | 3 payments
|
| Otsuka America Pharmaceutical | Rexulti | $122 | 1 payment
|
| Axsome Therapeutics | Auvelity | $122 | 1 payment
|
See all 5 published payments
| Teva Pharmaceuticals USA | Meals · 2025-11-13 | Uzedy | $124 |
| Axsome Therapeutics | Meals · 2025-04-07 | Auvelity | $122 |
| Teva Pharmaceuticals USA | Meals · 2025-03-12 | Uzedy | $120 |
| Otsuka America Pharmaceutical | Meals · 2025-01-22 | Rexulti | $122 |
| Teva Pharmaceuticals USA | Meals · 2025-01-14 | Uzedy | $125 |
See earlier years (2024, 2023, 2022, 2021)
2024: $667
| Teva Pharmaceuticals USA | Uzedy | $317 | 5 payments
|
| Biogen | Zurzuvae | $122 | 1 payment
|
| Axsome Therapeutics | Auvelity | $109 | 1 payment
|
| Alkermes | Lybalvi | $102 | 1 payment
|
| Janssen Pharmaceuticals | Invega Sustenna | $17 | 1 payment
|
2023: $1,497
| Janssen Pharmaceuticals | Invega Sustenna | $485 | 5 payments
|
| Teva Pharmaceuticals USA | Uzedy | $369 | 3 payments
|
| Iti | Caplyta | $245 | 2 payments
|
| Abbvie | Vraylar | $125 | 1 payment
|
| Lilly USA | Olumiant | $121 | 1 payment
|
| Alkermes | Aristada | $117 | 1 payment
|
| Indivior | Perseris | $35 | 2 payments
|
2022: $1,324
| Janssen Pharmaceuticals | Invega Sustenna | $322 | 4 payments
|
| Teva Pharmaceuticals USA | Austedo | $244 | 2 payments
|
| Iti | Caplyta | $125 | 1 payment
|
| Abbvie | None | $125 | 1 payment
|
| SK Life Science | Xcopri | $124 | 1 payment
|
| Ultragenyx Pharmaceutical | Crysvita | $122 | 1 payment
|
| Alkermes | Lybalvi | $100 | 1 payment
|
| Janssen Scientific Affairs | None | $85 | 1 payment
|
| Abbott Laboratories | Proclaim | $78 | 1 payment
|
2021: $557
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $216 | 2 payments
|
| Alkermes | Aristada | $125 | 1 payment
|
| Teva Pharmaceuticals USA | Austedo | $121 | 1 payment
|
| Biogen | None | $96 | 1 payment
|
Professional record
- NPI
- 1720449358
- Licence
- CA 2018015179, CA 95002098
- Group
- Special Service for Groups Inc · Mellow Medical Inc A Professional Corporation
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X); Federal specialty code 363LF0000X (363LF0000X); Federal specialty code 363LP0808X (363LP0808X)
- Mailing address
- 200 S Manchester Ave Ste 300, Orange, CA, 92868
- NPI first listed
- 2016-03-09
- NPI last updated
- 2024-01-24
- NPI record certified
- 2024-01-24
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 333 City Blvd W, Orange, CA, 92868